Technology advance could enable the use of ophthalmologic OCT systems at home

Researchers have shown that a vertical cavity surface emitting laser (VCSEL) diode, which is commonly used in telecommunications and lidar applications, could offer a less expensive light source for swept-source optical coherence tomography (OCT). This advance could lead to ophthalmologic OCT systems that are practical for use outside the ophthalmology clinic, even at home.

OCT has become a standard imaging tool in ophthalmology for diagnosing and monitoring diseases like glaucoma, macular degeneration and diabetes-related retinopathy. However, the price of laser sources and the complexity of OCT systems hinder its accessibility outside of clinics and hospitals, in particular for home care or point-of-care use."

Milana Kendrisic, research team member, Medical University of Vienna in Austria

Although single-mode VSCELs usually operate using a constant current, the researchers varied the current to achieve the changes in the wavelength, or color, needed for swept source OCT. In the Optica Publishing Group journal Optics Letters, the researchers describe their custom OCT setup that incorporates a VCSEL and advanced post-processing algorithms. They used the setup to obtain full-eye scans on a healthy volunteer.

"We want to develop a low-cost OCT device that could be used in a general practitioner's office, a pharmacy or even a supermarket to allow eye checkups without going to the ophthalmologist," said Kendrisic. "It could also allow home-based treatment monitoring for patients with age-related macular degeneration or eye health in diabetes patients to monitor treatment or catch abnormal changes early, avoiding loss of vision and ultimately preserving quality of life. This might be done by renting an easy-to-use device from your insurance provider, for example."

Finding a less expensive laser

Swept-source OCT is a relatively new OCT approach that became clinically available for eye imaging in 2010. It uses a laser that changes wavelengths over time to enable high-quality visualization of multiple parts of the eye. Although this new approach reveals details that are being used to better understand and diagnose eye disorders, swept-source lasers usually cost tens of thousands of dollars.

In the new work, the researchers set out to see if a much cheaper VCSEL diode could be used in place of the expensive swept-source laser. While VCSEL diodes typically produce a laser output beam at a certain well-defined wavelength, if the diode's operating temperature changes, the output wavelength will also change.

"Our idea was to leverage an unwanted effect of wavelength shifting with temperature to make these diodes usable for OCT," said Kendrisic. "We deliberately induce a temperature change by ramping up the driving current in a short time to high values beyond its original specifications. This is followed by a cooling period to avoid deterioration of the diode material, which lets us tune the diode over a broader bandwidth than is otherwise possible."

Although other groups have demonstrated that VCSELs can be used for OCT, those systems were not designed for eye imaging. Because the eye is mostly filled with water, the researchers used a VCSEL that operates at 850 nm, a wavelength that isn't absorbed strongly by water. This allows the laser light to travel through the eye to the retina and back to the detector without losing the signal to absorption.

"Even though commercial swept sources have larger spectral bandwidths, we showed that even the small range we achieved with a VCSEL is sufficient to perform OCT," said Kendrisic. "These laser diodes could cost as little as a few dollars each if bought in bulk and also allow large distance ranging, which is needed for covering the full length of the human eye from cornea to retina."

Acquiring images of the eye

After figuring out the best way to increase current to the VCSEL without damaging the laser while also ensuring the best possible resolution for imaging, the researchers incorporated it into an optical setup for performing ophthalmic OCT imaging. This system, which included some extra components to maintain system performance and advanced post-processing algorithms, performed very well, especially in terms of sensitivity and imaging depth.

They then tested the system by using it to image the eye of a healthy volunteer and were able to extract biometric information such as the axial eye length and anterior chamber depth with axial precision comparable to commercial OCT systems. The results also show the potential of the technology for use in biometric eye scanner systems used for security purposes.

"Although VSCEL-based systems have some limitations in terms of image quality, they still have the potential to expand access to diagnostic imaging and improve patient care in areas where traditional OCT systems may not be available or affordable," said Kendrisic. "Our paper emphasizes the use of this technology for ophthalmic applications, but lowering the price of OCT devices will allow an easier introduction of OCT technology in other fields as well – both medical and technical."

Before a VSCEL-based system could be commercialized for eye exams, large scale clinical studies and source lifetime tests would need to be performed to prove the system's clinical relevance and longevity.

Journal reference:

Kendrisic, M., et al. (2023) Thermally tuned VCSEL at 850 nm as a low-cost alternative source for full-eye SS-OCT. Optics Letters.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide linked to increased risk of severe eye condition NAION in new study